TARDBP and disease arising from reactivation of latent virus: TDP-43 has been shown to be potentially involved in both HIV-1 [270] as well as in HSV-2 [271] latency and cell permittivity, suggesting a possible role for TDP-43 in HIV-1 and HSV-2-associated neurodegeneration in latent infection.